Drug that doesn't work on Alzheimer's

Alzheimer’s and Amyloid: Understanding the Link to Brain Health

Alzheimer’s disease is closely associated with the buildup of amyloid-beta plaques, abnormal protein deposits that accumulate between brain cells and disrupt communication. These sticky clusters are considered one of the hallmark features of Alzheimer’s pathology, contributing to memory loss, cognitive decline, and neurodegeneration. Research shows that amyloid buildup triggers inflammation, oxidative stress, and damage to neurons, which accelerates the progression of dementia.

Detecting and targeting amyloid plaques is a major focus in modern Alzheimer’s research. Advanced imaging techniques, genetic testing, and innovative therapies aim to reduce or prevent amyloid aggregation, offering hope for early intervention and treatment. Lifestyle factors—such as nutrition, exercise, sleep quality, and vascular health—may also influence amyloid clearance and brain resilience.

By understanding the connection between amyloid and Alzheimer’s disease, individuals can take proactive steps toward brain health, prevention strategies, and potential future treatments.